Acta Neurologica Scandinavica logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 115, Number 4, April 2007

< previous issue | all issues | next issue >

Mitochondrial diseases: a nosological update
pp. 211-221(11)
Authors: Filosto, M.; Mancuso, M.

Topiramate and physiologic measures of nerve function in polyneuropathy
pp. 222-231(10)
Authors: Freeman, R.; McIntosh, K. A.; Vijapurkar, U.; Thienel, U.

Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition
pp. 232-242(11)
Authors: Simon, C.; Stieger, B.; Kullak-Ublick, G. A.; Fried, M.; Mueller, S.; Fritschy, J.-M.; Wieser, H.G.; Pauli-Magnus, C.

BNCT for recurrent intracranial meningeal tumours – case reports
pp. 243-247(5)
Authors: Stenstam, B. H.; Pellettieri, L.; Sorteberg, W.; Rezaei, A.; Sköld, K.

The apolipoprotein E 4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities
pp. 248-253(6)
Authors: Høgh, P.; Garde, E.; Mortensen, E. L.; Jørgensen, O. S.; Krabbe, K.; Waldemar, G.

Cerebrospinal fluid protein reactions during non-neurological surgery
pp. 254-259(6)
Authors: Anckarsäter, R.; Vasic, N.; Jidéus, L.; Kristiansson, M.; Zetterberg, H.; Blennow, K.; Anckarsäter, H.

Multiple sclerosis in Latter Day Saints (Mormons)
pp. 260-264(5)
Authors: Hawkes, C. H.; Ramkumar, N.; Baker, R.; Lyon, J. L.

Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I
pp. 265-270(6)
Authors: Kalkman, J. S.; Schillings, M. L.; Zwarts, M. J.; van Engelen, B. G. M.; Bleijenberg, G.

Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation
pp. 271-274(4)
Authors: Ito, H.; Ito, H.; Nakano, S.; Kusaka, H.

Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease?
pp. 275-278(4)
Authors: Halperin, A.; Elstein, D.; Zimran, A.

A clinical and immunological study of a myasthenia gravis patient treated with infliximab
pp. 279-283(5)
Authors: Kakoulidou, M.; Bjelak, S.; Pirskanen, R.; Lefvert, A. K.

Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy
pp. 284-288(5)
Authors: Beydoun, S.; Alarcón, F.; Mangat, S.; Wan, Y.

Use of immunoglobulin in severe childhood Guillain-Barré syndrome
pp. 289-293(5)
Authors: Ortiz-Corredor, F.; Peña-Preciado, M.

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page